ARGENTA ANNOUNCES COLLABORATION WITH PAINCEPTOR

Argenta Discovery Ltd. has announced that it has entered into development collaboration with PainCeptor Pharma Corp. Under the terms of the agreement, scientists from the two companies will exploit Argenta's expertise in computer-aided drug design and medicinal chemistry to accelerate PainCeptor's ASIC (acid-sensing ion channel) development programme for pain therapeutics, targeting these sensory mechanisms which are associated with a variety of pain-related conditions, including cancer and arthritis.

CombiChem.net (http://www.combichem.net/index.aspx?ID=72120)